raloxifene has been researched along with Invasiveness, Neoplasm in 2 studies
raloxifene : A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogens at positions 2, 3, and 6 have been replaced by p-hydroxyphenyl, p-[2-(piperidin-1-yl)ethoxy]benzoyl, and hydroxy groups, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scott, SA | 1 |
Selvy, PE | 1 |
Buck, JR | 1 |
Cho, HP | 1 |
Criswell, TL | 1 |
Thomas, AL | 1 |
Armstrong, MD | 1 |
Arteaga, CL | 1 |
Lindsley, CW | 1 |
Brown, HA | 1 |
Chakravarti, B | 1 |
Akhtar, T | 1 |
Rai, B | 1 |
Yadav, M | 1 |
Akhtar Siddiqui, J | 1 |
Dhar Dwivedi, SK | 1 |
Thakur, R | 1 |
Singh, AK | 2 |
Kumar, H | 1 |
Khan, K | 1 |
Pal, S | 1 |
Rath, SK | 1 |
Lal, J | 1 |
Konwar, R | 1 |
Trivedi, AK | 1 |
Datta, D | 1 |
Mishra, DP | 1 |
Godbole, MM | 1 |
Sanyal, S | 1 |
Chattopadhyay, N | 1 |
Kumar, A | 1 |
2 other studies available for raloxifene and Invasiveness, Neoplasm
Article | Year |
---|---|
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Topics: Breast Neoplasms; Drug Design; Enzyme Inhibitors; Humans; Isoenzymes; Neoplasm Invasiveness; Phospho | 2009 |
Thioaryl naphthylmethanone oxime ether analogs as novel anticancer agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzhydryl Compounds; Cell Cycle; Cell Line, Tumor; Cell | 2014 |